Genetic workup diagnosed skeletal disorders in 73.6% of families studied

A genetic diagnosis was established in 134 of 182 families (73.6%) investigated for genetic skeletal disorders using genome sequencing and follow-up assessments. The study included 186 children and adults investigated between 2015 and 2022. Initial sequencing analysis identified 125 diagnoses (68.7%). Reanalysis, meaning another examination of the sequencing results, or investigations involving relatives yielded nine additional diagnoses (4.9%).
The patients had clinical features and X-ray findings consistent with genetic skeletal disorders. Researchers investigated their conditions using short-read genome sequencing, which reads DNA in small sections. They reviewed clinical information and skeletal X-rays according to the 2023 International Nosology of Genetic Skeletal Disorders, a classification of these conditions.
For patients who remained without a genetic diagnosis, researchers reassessed their clinical features and conducted further analyses. These included updated gene panels, sets of genes selected for examination, and sequencing involving family members. The additional work brought the total number of families with a diagnosis to 134.
Diagnoses were based on DNA changes classified as pathogenic or likely pathogenic, meaning disease-causing or probably disease-causing. Autosomal dominant disorders accounted for 69% of diagnoses. In these disorders, a change in one gene copy can cause disease. Autosomal recessive disorders, which require changes in both gene copies, accounted for 24%. Disorders linked to the X chromosome accounted for 7%.
Nine families had DNA changes of uncertain significance in genes consistent with their clinical features. These findings did not establish a genetic diagnosis. They included changes in both copies of COL10A1 and UFSP2. Those genes are associated with autosomal dominant disease, in which one altered copy can cause disease, but the significance of the changes found in both copies remained uncertain. A likely non-genetic cause was identified in five families.
The nine additional diagnoses show the contribution of revisiting sequencing results or investigating relatives after the initial analysis. The authors concluded that genome sequencing was effective at identifying a broad range of disease-causing DNA changes, particularly when combined with detailed clinical assessment, skeletal X-rays and reanalysis.
Written by the Genomes desk from the primary source cited and linked above and checked against it. Research use only; not medical advice. Corrections: [email protected].